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Fas gets protective
 
A deadly receptor reveals a benevolent side in a
study on page 575. Landau and colleagues show
that the cell death–inducing receptor Fas is re-
quired for protection against neurodegeneration
in a mouse model of Parkinson’s disease (PD).
The Fas receptor (Fas), best known for its
apoptotic role in the immune system, is widely
expressed in nonimmune tissues, including
the central nervous system. In the brains of
patients with PD, the expression of both Fas
and Fas ligand (FasL) is reduced, whereas the
expression of soluble Fas is elevated. Soluble
Fas is a decoy receptor that impairs Fas signaling
by competing for free ligand. Apoptosis has
been implicated in PD neurodegeneration,
but this occurs independently of caspase-8, an
upstream activator in Fas-mediated apoptosis,
suggesting that Fas may not be the predominant
death inducer in PD.
Using mice with Fas/FasL mutations, the
authors showed that decreased Fas expression
increased susceptibility to a PD-causing neuro-
toxin. Neuronal cell loss was markedly increased
in Fas-deficient mice, and these mice developed
severe PD symptoms within days of toxin
exposure. In contrast, two strains of mice that
express Fas but have mutations in the Fas
death domain, a region responsible for apop-
totic signaling, were resistant to PD.
Fas defects might also underlie PD in
humans, as circulating T cells from patients
with PD failed to up-regulate Fas expression in
response to mitogenic stimulation. Although
the Fas-induced signals that protect the brain
have yet to be identified, these findings suggest
that, in this model of PD, Fas-induced neuro-
protection trumps Fas-induced cell death. 
Loss of dopamine-containing neurons (red) is accel-
erated in the brains of Fas-deficient mice (bottom).
 
T cell CRAC dependence
 
Calcium transport is critical for the activation of transcription pathways
that drive T cell proliferation and function. On page 651, Feske and col-
leagues show that Ca
 
2
 
 
 
 release–activated Ca
 
2
 
 
 
 (CRAC) channels in the
plasma membrane are the major, if not only, pathway for T cell recep-
tor–activated calcium influx in T cells. The mechanism of activation and
identity of these CRAC channels continues to elude researchers.
The authors analyzed channels in T cells from patients with a form of
severe congenital immunodeficiency (SCID) that is characterized by im-
paired T cell activation and a near total lack of calcium influx. Using
electrophysiological techniques, they showed that the lack of calcium in-
flux was due to a complete failure of CRAC channel opening, and not a
consequence of dysregulated intracellular calcium stores or aberrant ex-
pression of other suspected ion channels. The authors believe that the
CRAC channels are present in the patients’ T cells but that their activa-
tion is somehow impaired.
The specificity and severity of the defect in T cells from the SCID
patients provide a powerful tool to pinpoint the identity of the CRAC
channel and determine its mode of activation. The authors are now us-
ing positional cloning approaches and genetic complementation to try
to isolate the underlying molecular components. 
 
Trashing 
 
Salmonella
 
Macrophages use nitric oxide (NO) to gain the upper hand against 
 
Salmonella
 
 
infection, according to a study on page 625. McCollister and colleagues 
show that NO released by macrophages foils 
 
Salmonella
 
’s attempts to avoid 
degradation in lysosomes.
 
Salmonella
 
 is an enteric pathogen that infects macrophages and causes 
illnesses ranging from mild gastroenteritis to potentially fatal systemic 
disease. Once inside macrophages, 
 
Salmonella
 
 avoid the cells’ antimicrobial 
defenses using a specialized protein secretion system. This system, known as 
the 
 
Salmonella
 
 pathogenicity island 2 (SPI2) type III secretion system, injects 
proteins from the bacteria-containing phagosome into the cytosol of the 
infected cell. These proteins disrupt normal vesicular trafficking and prevent 
the fusion of the phagosome with the degradative lysosomes where the 
bacteria would be digested. 
 
Salmonella
 
 with a defective SPI2 system survive 
poorly in macrophages and are unable to cause systemic disease.
Previous studies have shown that 
interferon (IFN)-
 
 
 
–induced activation 
of macrophages is essential for 
effective defense against 
 
Salmonella
 
 
infections. McCollister and colleagues 
now show that IFN-
 
 
 
 helps outsmart 
the bacteria by inducing the sustained 
production of NO by macrophages. 
Macrophage-produced NO inhibited 
transcription of the sensor kinase that 
controls the SPI2 system. Without the 
SPI2 system in place, the 
 
Salmonella
 
-
containing phagosomes were free to 
fuse with lysosomes and the bacteria 
were destroyed. 
NO produced by activated macro-
phages inhibits expression of the 
Salmonella SPI2 system, which 
destines the bacteria (green) for 
degradation in late endosomes/
lysosomes (red).
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